We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-0.01%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$35.6B
AUM Growth
+$1.38B
(+4%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
5.13%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
2,407
New
40
Increased
606
Reduced
1,352
Closed
406
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$172M |
| 2 |
Honeywell
HON
|
+$160M |
| 3 |
Microsoft
MSFT
|
+$159M |
| 4 |
Amazon
AMZN
|
+$91M |
| 5 |
Tesla
TSLA
|
+$89.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.3M |
| 2 |
STMP
Stamps.com, Inc.
STMP
|
+$42.3M |
| 3 |
Magnite
MGNI
|
+$36.1M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$34.8M |
| 5 |
Etsy
ETSY
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Consumer Discretionary | 14.43% |
| 3 | Communication Services | 10.72% |
| 4 | Healthcare | 9.96% |
| 5 | Financials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Kymera Therapeutics
KYMR
$9.1B
| $259K | ﹤0.01% |
4,405
-3,094
| -41% | -$179K |
|
1652
Verra Mobility
VRRM
$615M
| $259K | ﹤0.01% |
17,186
-17,603
| -51% | -$269K |
|
1653
Immunovant
IMVT
$8.09B
| $258K | ﹤0.01% |
29,701
+2,366
| +9% | +$21.3K |
|
1654
Knowles
KN
$3.22B
| $258K | ﹤0.01% |
13,781
-11,834
| -46% | -$231K |
|
|
FOE
1655
DELISTED
Ferro Corporation
FOE
| $258K | ﹤0.01% |
12,662
-10,901
| -46% | -$226K |
|
1656
Chord Energy
CHRD
$7.79B
| $257K | ﹤0.01% |
2,587
-2,648
| -51% | -$244K |
|
1657
Collegium Pharmaceutical
COLL
$1.14B
| $257K | ﹤0.01% |
13,026
-3,396
| -21% | -$73.4K |
|
1658
Live Oak Bancshares
LOB
$1.95B
| $257K | ﹤0.01% |
4,043
-4,135
| -51% | -$245K |
|
1659
PennyMac Financial
PFSI
$4.38B
| $257K | ﹤0.01% |
4,207
-4,957
| -54% | -$315K |
|
1660
Tanger
SKT
$4.82B
| $257K | ﹤0.01% |
15,769
-12,710
| -45% | -$221K |
|
1661
CorVel
CRVL
$3.05B
| $256K | ﹤0.01% |
4,119
-3,489
| -46% | -$182K |
|
1662
EPR Properties
EPR
$4.86B
| $256K | ﹤0.01% |
5,184
-485
| -9% | -$24.6K |
|
1663
M/I Homes
MHO
$3.83B
| $256K | ﹤0.01% |
4,422
-3,785
| -46% | -$232K |
|
1664
Repay Holdings
RPAY
$315M
| $256K | ﹤0.01% |
11,103
-8,871
| -44% | -$208K |
|
|
EGRX
1665
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $256K | ﹤0.01% |
4,584
-1,102
| -19% | -$54.2K |
|
|
MDRX
1666
DELISTED
Veradigm Inc. Common Stock
MDRX
| $256K | ﹤0.01% |
19,110
-21,035
| -52% | -$340K |
|
1667
Pathward Financial
CASH
$1.81B
| $255K | ﹤0.01% |
4,855
-4,170
| -46% | -$208K |
|
1668
Unisys
UIS
$227M
| $255K | ﹤0.01% |
10,145
-8,708
| -46% | -$206K |
|
|
ILPT
1669
Industrial Logistics Properties Trust
ILPT
$613M
| $254K | ﹤0.01% |
10,014
-8,618
| -46% | -$230K |
|
1670
MYR Group
MYRG
$5.9B
| $254K | ﹤0.01% |
2,553
-2,188
| -46% | -$215K |
|
1671
American Well
AMWL
$181M
| $253K | ﹤0.01% |
1,386
-1,245
| -47% | -$270K |
|
1672
Gray Television
GTN
$407M
| $251K | ﹤0.01% |
10,983
-11,220
| -51% | -$248K |
|
|
ADAM
1673
Adamas Trust
ADAM
$777M
| $250K | ﹤0.01% |
14,648
-12,593
| -46% | -$219K |
|
1674
Dave & Buster's
PLAY
$343M
| $250K | ﹤0.01% |
6,532
-5,980
| -48% | -$216K |
|
|
AFMD
1675
DELISTED
Affimed
AFMD
| $249K | ﹤0.01% |
4,029
-1,120
| -22% | -$73.7K |
|
Similar funds
ProShare Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, ProShare Advisors held 2,407 positions worth $35.6B, up 4% from $34.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
ProShare Advisors deployed $1.82B of net new capital in Q3 2021, opening 40 new positions and adding to 606 existing holdings. Its largest new stake was Sea Limited: 95,823 shares worth $30.5M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Stamps.com, Inc., an estimated $42.3M trimmed.
- ProShare Advisors's largest Q3 2021 buy was Sea Limited: 95,823 shares worth $30.5M.
- ProShare Advisors added most to Apple in Q3 2021, an estimated $172M increase.
- ProShare Advisors's biggest Q3 2021 reduction was Stamps.com, Inc., cutting an estimated $42.3M.
- ProShare Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $53.3M.
- ProShare Advisors's ten largest holdings make up 28% of its $35.6B portfolio in Q3 2021.
- ProShare Advisors opened 40 new positions and closed 406 in Q3 2021.
- ProShare Advisors's portfolio value rose 4% quarter-over-quarter to $35.6B.
Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.